Lifeng Wang

658 total citations
34 papers, 504 citations indexed

About

Lifeng Wang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lifeng Wang has authored 34 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lifeng Wang's work include Gastric Cancer Management and Outcomes (5 papers), Glioma Diagnosis and Treatment (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Lifeng Wang is often cited by papers focused on Gastric Cancer Management and Outcomes (5 papers), Glioma Diagnosis and Treatment (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Lifeng Wang collaborates with scholars based in China, United States and France. Lifeng Wang's co-authors include Ruifen Wang, Wenbin Guan, Hongmei Wu, Wenguang Sun, Mawei Jiang, Meng Qiao, Xiaojun Yuan, Jia Liu, Leizhen Zheng and Meiling Zhu and has published in prestigious journals such as Cancer Research, Scientific Reports and Journal of Cellular Physiology.

In The Last Decade

Lifeng Wang

32 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lifeng Wang China 16 244 177 144 110 94 34 504
Ramapriya Ganti United States 11 270 1.1× 179 1.0× 138 1.0× 141 1.3× 75 0.8× 15 600
Zhengwang Sun China 14 205 0.8× 135 0.8× 113 0.8× 141 1.3× 93 1.0× 46 532
Enrique Grande Pulido Spain 11 229 0.9× 220 1.2× 100 0.7× 93 0.8× 70 0.7× 35 530
Artit Jinawath Thailand 12 221 0.9× 133 0.8× 84 0.6× 68 0.6× 97 1.0× 32 451
Haoyue Hu China 11 251 1.0× 163 0.9× 140 1.0× 96 0.9× 66 0.7× 31 524
Tomoyo Yasui Japan 15 263 1.1× 202 1.1× 156 1.1× 72 0.7× 75 0.8× 58 637
Qirong Geng China 12 172 0.7× 112 0.6× 117 0.8× 158 1.4× 119 1.3× 27 469
Roelof Koster Netherlands 11 351 1.4× 210 1.2× 118 0.8× 85 0.8× 197 2.1× 23 672
Prakash Peddi United States 13 201 0.8× 282 1.6× 125 0.9× 129 1.2× 94 1.0× 33 560
Satoe Fujiwara Japan 14 279 1.1× 227 1.3× 169 1.2× 72 0.7× 89 0.9× 38 677

Countries citing papers authored by Lifeng Wang

Since Specialization
Citations

This map shows the geographic impact of Lifeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifeng Wang more than expected).

Fields of papers citing papers by Lifeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lifeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifeng Wang. The network helps show where Lifeng Wang may publish in the future.

Co-authorship network of co-authors of Lifeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lifeng Wang. A scholar is included among the top collaborators of Lifeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lifeng Wang. Lifeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Lifeng, Jacky Chi Ki Ngo, Magali Perier, et al.. (2024). Magnetic microelastography for evaluation of ultrasound-induced softening of pancreatic cancer spheroids. Physical Review Applied. 22(2).
2.
Huang, Wanqiu, et al.. (2024). CAPZB mRNA is a novel biomarker for cervical high-grade squamous lesions. Scientific Reports. 14(1). 20047–20047. 2 indexed citations
3.
Shen, Yan, Qingyu Cui, Xiao Li, et al.. (2023). Down-regulated Wnt7a and GPR124 in early-onset preeclampsia placentas reduce invasion and migration of trophoblast cells. Journal of Perinatal Medicine. 52(1). 41–49. 2 indexed citations
4.
Wang, Lifeng, et al.. (2022). Bilateral Thalamic Gliomas Harboring Alterations of EGFR and H3K27M: An Integrated Clinicopathological Characteristics Case Series. World Neurosurgery. 168. e442–e450. 1 indexed citations
6.
Wang, Lifeng, et al.. (2022). Fluorometholone inhibits high glucose-induced cellular senescence in human retinal endothelial cells. Human & Experimental Toxicology. 41. 3520094347–3520094347. 8 indexed citations
7.
Feng, Jian, et al.. (2021). Survival Outcomes of Lobectomy Versus Segmentectomy in Clinical Stage I Non-Small Cell Lung Cancer: A Meta-Analysis. Advances in Therapy. 38(7). 4130–4137. 4 indexed citations
8.
Wang, Shujie, Wenjing Liu, Lifeng Wang, et al.. (2021). Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer. Journal of Cancer. 12(9). 2550–2559. 6 indexed citations
9.
Xi, Lili, Yaqing Chen, Jun Jiang, et al.. (2019). The value of contrast enhanced ultrasound in breast cancer biopsy. Zhonghua chaosheng yingxiangxue zazhi. 28(9). 782–786.
10.
Guan, Wenbin, Lei Cai, Meng Qiao, et al.. (2019). <p>Integrated assessment of PD-L1 expression and molecular classification facilitates therapy selection and prognosis prediction in gastric cancer</p>. Cancer Management and Research. Volume 11. 6397–6410. 18 indexed citations
11.
Li, Shu, Wenhao Zhang, Chao Wu, et al.. (2018). HOXC10 promotes proliferation and invasion and induces immunosuppressive gene expression in glioma. FEBS Journal. 285(12). 2278–2291. 38 indexed citations
12.
Wang, Yi, et al.. (2017). Analysis of Recurrent Sacrococcygeal Teratoma in Children: Clinical Features, Relapse Risks, and Anorectal Functional Sequelae. Medical Science Monitor. 23. 17–23. 23 indexed citations
13.
Wang, Yiwei, Hongjia Li, Ruifen Wang, et al.. (2017). Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in Early Gastric Cancer (EGC). Journal of Cancer. 8(8). 1477–1483. 2 indexed citations
14.
Wang, Lifeng, et al.. (2016). Follicular dendritic cell sarcoma of the spleen: A case report and review of the literature. Oncology Letters. 12(3). 2062–2064. 13 indexed citations
16.
Wang, Lifeng, et al.. (2014). Caveolin-1 expression in different types of psoriatic lesions: Analysis of 66 cases. Indian Journal of Dermatology. 59(3). 225–225. 11 indexed citations
17.
Wang, Lifeng, et al.. (2012). The Role of SPARC Protein Expression in the Progress of Gastric Cancer. Pathology & Oncology Research. 18(3). 697–702. 29 indexed citations
18.
Wang, Zhengcai, et al.. (2012). Effects of cancer-associated fibroblasts on the migration and invasion abilities of SGC-7901 gastric cancer cells. Oncology Letters. 5(2). 609–612. 22 indexed citations
19.
Wang, Lifeng, et al.. (2011). The MLH12101C>A (Q701K) variant increases the risk of gastric cancer in Chinese males. BMC Gastroenterology. 11(1). 133–133. 10 indexed citations
20.
Wei, Jia, Baorui Liu, Lifeng Wang, et al.. (2007). Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines. Cancer Chemotherapy and Pharmacology. 60(5). 703–711. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026